These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 21324344
1. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1. Xu W, Liu J, Gong W, Chen J, Zhu S, Zhang L. Vaccine; 2011 Mar 24; 29(15):2672-8. PubMed ID: 21324344 [Abstract] [Full Text] [Related]
2. Expression of HPV6b L1/EBV LMP2 multiepitope and immunogenicity in mice. Zhu S, Xue X, Liu J, Lu L, Zhao P, Wang J, Li W, Zhang L. Acta Biochim Biophys Sin (Shanghai); 2010 Aug 24; 42(8):515-21. PubMed ID: 20705592 [Abstract] [Full Text] [Related]
3. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection. Wang L, Cai Y, Xiong Y, Du W, Cen D, Zhang C, Song Y, Zhu S, Xue X, Zhang L. Oncotarget; 2017 May 16; 8(20):33241-33251. PubMed ID: 28402260 [Abstract] [Full Text] [Related]
4. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice. Zhu S, Feng Y, Rao P, Xue X, Chen S, Li W, Zhu G, Zhang L. Appl Microbiol Biotechnol; 2014 May 16; 98(9):4107-17. PubMed ID: 24458565 [Abstract] [Full Text] [Related]
5. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen. Hadad R, Marks E, Kalbina I, Schön K, Unemo M, Lycke N, Strid Å, Andersson S. APMIS; 2016 Dec 16; 124(12):1078-1086. PubMed ID: 27859689 [Abstract] [Full Text] [Related]
6. [Immunogenicity of multi-epitopes gene of major outer membrane protein of Chlamydia trachomatis]. Zhu SL, Shi ZH, Li WS, Chen J, Zhang LF. Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Mar 16; 43(3):232-6. PubMed ID: 19534931 [Abstract] [Full Text] [Related]
7. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice. Tu J, Hou B, Wang B, Lin X, Gong W, Dong H, Zhu S, Chen S, Xue X, Zhao KN, Zhang L. Acta Biochim Biophys Sin (Shanghai); 2014 May 16; 46(5):401-8. PubMed ID: 24681882 [Abstract] [Full Text] [Related]
8. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K. Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585 [Abstract] [Full Text] [Related]
9. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections. Hickey DK, Aldwell FE, Beagley KW. Vaccine; 2009 Oct 19; 27(44):6217-25. PubMed ID: 19698810 [Abstract] [Full Text] [Related]
11. Induction of a protective immune response against swine Chlamydophila abortus infection in mice following co-vaccination of omp-1 DNA with recombinant MOMP. Zhang F, Li S, Yang J, Yang L, He C. Zoonoses Public Health; 2009 Mar 19; 56(2):71-6. PubMed ID: 18721226 [Abstract] [Full Text] [Related]
13. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model. Hansen J, Jensen KT, Follmann F, Agger EM, Theisen M, Andersen P. J Infect Dis; 2008 Sep 01; 198(5):758-67. PubMed ID: 18652549 [Abstract] [Full Text] [Related]
14. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model. Jiang P, Cai Y, Chen J, Ye X, Mao S, Zhu S, Xue X, Chen S, Zhang L. Vaccine; 2017 May 25; 35(23):3096-3103. PubMed ID: 28456528 [Abstract] [Full Text] [Related]
15. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Campos M, Pal S, O'Brien TP, Taylor HR, Prendergast RA, Whittum-Hudson JA. Invest Ophthalmol Vis Sci; 1995 Jul 25; 36(8):1477-91. PubMed ID: 7601629 [Abstract] [Full Text] [Related]
16. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination. Zheng Y, Zhao WM, Wang H, Zhou YB, Luan Y, Qi M, Cheng YZ, Tang W, Liu J, Yu H, Yu XP, Fan YJ, Yang X. Biochem Cell Biol; 2007 Apr 25; 85(2):218-26. PubMed ID: 17534403 [Abstract] [Full Text] [Related]
17. Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis. Zhu S, Chen J, Zheng M, Gong W, Xue X, Li W, Zhang L. Acta Biochim Biophys Sin (Shanghai); 2010 Nov 25; 42(11):771-8. PubMed ID: 20923859 [Abstract] [Full Text] [Related]
18. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa. Schautteet K, Stuyven E, Beeckman DS, Van Acker S, Carlon M, Chiers K, Cox E, Vanrompay D. Vaccine; 2011 Feb 04; 29(7):1399-407. PubMed ID: 21195805 [Abstract] [Full Text] [Related]
19. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO. FEMS Immunol Med Microbiol; 2007 Feb 04; 49(1):46-55. PubMed ID: 17094789 [Abstract] [Full Text] [Related]
20. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU. Vaccine; 2003 Apr 02; 21(15):1694-703. PubMed ID: 12639492 [Abstract] [Full Text] [Related] Page: [Next] [New Search]